Catalyst Wire Dossier Catalyst Wire Dossier

Neramexane Mesylate

neramexane mesylate · Merz Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Neramexane Mesylate, covering 2011-02-08 to 2011-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects [Phase 1]

See pricing